LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 105.425 USD -1.55%
Market Cap: 2.4B USD
Have any thoughts about
LeMaitre Vascular Inc?
Write Note

LeMaitre Vascular Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LeMaitre Vascular Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
LeMaitre Vascular Inc
NASDAQ:LMAT
Net Change in Cash
$2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-5%
Becton Dickinson and Co
NYSE:BDX
Net Change in Cash
$375m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Net Change in Cash
$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Change in Cash
$2B
CAGR 3-Years
N/A
CAGR 5-Years
131%
CAGR 10-Years
23%
Abbott Laboratories
NYSE:ABT
Net Change in Cash
-$848m
CAGR 3-Years
N/A
CAGR 5-Years
24%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Net Change in Cash
-$1.2B
CAGR 3-Years
-267%
CAGR 5-Years
-98%
CAGR 10-Years
-29%
No Stocks Found

LeMaitre Vascular Inc
Glance View

Market Cap
2.4B USD
Industry
Health Care

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.

LMAT Intrinsic Value
54.085 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is LeMaitre Vascular Inc's Net Change in Cash?
Net Change in Cash
2.9m USD

Based on the financial report for Sep 30, 2024, LeMaitre Vascular Inc's Net Change in Cash amounts to 2.9m USD.

What is LeMaitre Vascular Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-5%

Over the last year, the Net Change in Cash growth was 156%.

Back to Top